Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM53A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEBPZOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CELF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL2RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDGFRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
VN1R4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1GALT1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCSER2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM103A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on